Carcinoembryonic antigen (CEA) and cancer antigen 15-3 (CA15-3) in serum have been approved by the US Food and Drug Administration (FDA) as biomarkers for breast cancer. The gene discussed is CEACAM5; the disease is breast carcinoma.